https://clinicaltrials.gov/ct2/show/NCT03866317?type=Intr&cond=Lupus&phase=012345&lupd_s=02%2F21%2F2019&lupd_d=14
Condition : Discoid Lupus Erythematosus
Intervention : Drug: Secukinumab
Sponsors : Massachusetts General Hospital; Novartis
Not yet recruiting
A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus
NCT03866317
Thu, 07 Mar 2019 12:00:00 EST
